DOCSLIB.ORG

Oncogenes of DNA Tumor Viruses1

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Oncogenes of DNA Tumor Viruses1 [CANCER RESEARCH 48. 493-496. February I. 1988] Perspectives in Cancer Research Oncogenes of DNA Tumor Viruses1 Arnold J. Levine Department of Molecular Biology, Princeton University, Princeton, New Jersey 08544 Experiments carried out over the past 10-12 years have the cellular oncogenes. It will attempt to identify where more created a field or approach which may properly be termed the information is required or contradictions appear in the devel molecular basis of cancer. One of its major accomplishments oping concepts. Finally, this communication will examine ex has been the identification and understanding of some of the amples of cooperation between oncogenes and other gene prod functions of a group of cancer-causing genes, the oncogenes. ucts which modify the mode of action of the former. If we are The major path to the oncogenes came from the study of cancer- on the right track, then general principles may well emerge. causing viruses. The oncogenes have been recognized and stud Tumor formation in animals or transformation in cell culture ied by two separate but related groups of virologists focusing has been demonstrated with many different DNA-containing upon either the DNA (1) or RNA (2) tumor viruses (they even viruses (1). In most cases it has been possible to identify one or have separate meetings now that these fields have grown so a few viral genes and their products that are responsible for large). From their studies it has become clear that the oncogenes transformation or, in some cases, tumorigenesis. A list of these of each virus type have very different origins. Indeed it is a viral gene products is presented in Table 1. With two notable curious fact that virtually every group of the DNA viruses exceptions, infection of cells and selection for the transformed studied (papova-papilloma, adenoviruses, herpesviruses, hepad- phenotype always result in a clone of cells containing and naviruses, poxviruses) has a representative virus which has been expressing viral gene products (1) and in some cases, these viral shown to produce, or be closely associated with, tumors in proteins have been shown to be required for the maintenance animals. Many DNA viruses have been shown to be tumor of the transformed state (14). The first exception is HSV2-1 or viruses under the appropriate and often specialized circum -2 and CMV, where it has been difficult to find reproducible stances of an experiment (1). In contrast, among the thousands viral genetic information or gene products in transformed cells of RNA viruses, only the retroviruses contain examples of viral (15, 16). Several explanations have been put forth to account agents that cause tumors. While the viral oncogenes that reside for these observations: (a) a "hit-and-run" hypothesis where the in the genome of the DNA tumor viruses bear little or no viral gene products act (via inducing mutation, for example) homology to cellular genes, the oncogenes of retroviruses are and are then no longer required (17); (b) insertion of a small clearly derived from and are closely related to their cellular viral DNA element (a promoter, for example) in the chromo counterparts, the protooncogenes (3). The evidence demonstra some activating a cellular oncogene (16). The insertion-pro ting that viral (DNA tumor viruses) and cellular (RNA tumor moter model, demonstrated with other viruses (18), has yet to viruses) derived oncogenes participate in the development of a be proven with HSV or CMV; (c) the frequency of HSV or cancer cell is quite convincing and accepted by most critical CMV transformation in cell culture is so low (at background scientists in the field, but not without some reservations (4, 5). level) (15, 16) that no real proof exists for the transforming Research, pursuing the isolation and functions of the cellular abilities of these viruses. In this case no explanation or mech oncogenes, has proceeded rapidly and been very productive with anism of transformation would be required. Epidemiological frequent reviews of this field (6-8). Less visible but equally evidence for the role of HSV-1 or -2 or CMV in human cancer valuable is the information accumulating about the viral onco is not convincing and what was accepted previously (HSV-2 genes of DNA tumor viruses. The justifications for focusing on and cervical carcinoma) is, in light of new data, no longer held this topic are, in the end, the same reasons why the cellular to be correct (19). The other example of a DNA virus with no oncogenes are important in the understanding of cancer: (a) known oncogene or protooncogene is hepatitis B virus. The some of the DNA tumor viruses (human papilloma viruses 16, epidemiological association between chronic hepatitis B virus 18, 33; hepatitis B virus; Epstein-Barr virus) are closely and infection and hepatocellular carcinoma is quite excellent (10); continuously associated with specific human cancers and prob however, the mechanism of carcinogenic action is unclear. ably contribute to one of several events that cause these cancers Some ideas such as (a) an increased risk of mutagenic or (9-11); (b) a study of the mechanisms of action of these viral carcinogenic events following destruction caused by chronic oncogenes will provide fundamental information about the infection, (b) the polymerase of the virus (reverse transcriptase) control of cell growth. There is already good evidence that some has a high error frequency and acts as a "mutator gene", and viral transforming gene products act upon normal cellular pro (c) a yet-to-be-found HBV protein that can act as an oncogene tooncogene products and alter their activities or levels (12,13). or cooperate with an oncogene (i.e., we still need an assay to Other viral oncogenes act to bypass the normal cellular control detect it), have all been put forth to explain these data. The mechanisms regulated by the protooncogenes and their prod development of model systems such as transgenic animals car ucts. A little consideration and several key experiments lead to rying this virus or some isolated viral genes could go a long the conclusion that a study of the DNA viral oncogenes will way to testing some of these ideas (20). inevitably bring us back to the cellular protooncogenes. The majority of the DNA tumor viruses (Table 1) have genes The goal of this "Perspective" will be to focus upon the DNA that encode protein products that actively participate in the virus oncogenes and their interactions and relationships with creation of a cancer cell and the transformed phenotype (1). Received 10/1/87; accepted 10/28/87. 2The abbreviations used are: HSV, herpes simplex virus; CMV, cytomegalovi- 1This work was supported by Grants CA09528 and CA38757 from N1H and rus; BPV, bovine papilloma virus; EBV, Epstein-Barr virus; EGF, epidermal MV-47 from the American Cancer Society. growth factor; p53, a protein with a molecular weight of 53,000. 493 Downloaded from cancerres.aacrjournals.org on September 30, 2021. © 1988 American Association for Cancer Research. DNA TUMOR VIRUS ONCOGENES Table l DNA tumor virus oncogena Functions, location, mode Viruses Oncogenes of action Papovaviruses SV40 Large T-antigen Nucleus-membrane, +/—*transcription, mitogenic, tumor- specific transplantation antigen, complex-p53 Small t-antigen Cytoplasm Polyoma Large T-antigen Nucleus, +/—transcription, DNA synthesis Middle t-antigen Inner plasma membrane, perinuclear membranes, complex-sir Small t-antigen Cytoplasmic Papillomaviruses (BPV, human) ES protein Plasma membrane E6 protein Nucleus, membrane Adenoviruses E\\-M, 26,000 —transcription E \\-M, 36,000 + transcription E1B-AÕ,21,000 Nuclear membrane E\B-M, 55,000 mRNA transport, complex-p53 Herpesviruses Epstein-Barr virus Lymphoproliferative Latent membrane protein malignancy Epstein-Barr nuclear Nuclear antigen antigen-II Herpes simplex types 1 and 2 Cytomegalovirus Hepadnaviruses Hepatitis B virus Poxviruses (vaccinia) Vaccinia growth factor Related to EGF and transforming growth factor-a; binds to Rabbit fibroma EGF receptor-mitogen Yaba tumor virus Fowlpox These may be proteins localized in the nucleus (SV40-polyoma residues deleted, and so increased enzyme activity is achieved large T-antigen, BPV-E6, adenovirus EIA, El B proteins, EBV- via a similar loss of regulation (2). The second interaction of a Epstein-Barr nuclear antigen-2), in the cytoplasm (small t- viral transforming gene product with a cellular protooncogene antigens SV40, polyoma), or in or on the plasma membrane is observed with the SV40 large T-antigen-p53 association (12, (BPV-E5, Py middle t, EBV-LMP) (1). Some of these viral 31). In normal cells, p53 protein levels are kept low due to the oncogenes are tumor-specific transplantation antigens (SV40 short half-life (6-20 min) of this protein. In many transformed large T-antigen, probably adenovirus EIA) (21, 22) or are cells, p53 levels are 10 to 100-fold higher and the half-life of recognized by T-lymphocytes (the EBV-latent membrane pro p53 is much increased (32). In SV40 transformed cells, p53 is tein is likely to be the lymphocyte determined membrane anti found in an oligomeric protein complex with SV40 T-antigen, gen or LYDMA) (23). There has been a wide variety of func and temperature-sensitive mutants of T-antigen regulate p53 tions associated with these proteins. The SV40 large T-antigen levels in a temperature-sensitive fashion (33). p53 has been and adenovirus EIA gene products can negatively or positively shown to be an oncogene because complementary DNA clones regulate transcription of viral and probably cellular genes (24, of p53 can immortalize cells in culture (34) and cooperate with 25). The adenovirus ElB-A/r 55,000 protein appears to be the ras oncogene to transform primary rat cells (35). Indeed, involved in mRNA transport from the nuclear to the cyto p53 is the only oncogene to date which was first described by plasm ic compartments (26).
Load more

Recommended publications
  • Tätigkeitsbericht 2007/2008
    Tätigkeitsbericht 2007/2008 8 200 / 7 0 20 Tätigkeitsbericht Stiftung bürgerlichen Rechts Martinistraße 52 · 20251 Hamburg Tel.: +49 (0) 40 480 51-0 · Fax: +49 (0) 40 480 51-103 [email protected] · www.hpi-hamburg.de Impressum Verantwortlich Prof. Dr. Thomas Dobner für den Inhalt Dr. Heinrich Hohenberg Redaktion Dr. Angela Homfeld Dr. Nicole Nolting Grafik & Layout AlsterWerk MedienService GmbH Hamburg Druck Hartung Druck + Medien GmbH Hamburg Titelbild Neu gestaltete Fassade des Seuchenlaborgebäudes Tätigkeitsbericht 2007/2008 Heinrich-Pette-Institut für Experimentelle Virologie und Immunologie an der Universität Hamburg Martinistraße 52 · 20251 Hamburg Postfach 201652 · 20206 Hamburg Telefon: +49-40/4 80 51-0 Telefax: +49-40/4 80 51-103 E-Mail: [email protected] Internet: www.hpi-hamburg.de Das Heinrich-Pette-Institut ist Mitglied der Leibniz-Gemeinschaft (WGL) Internet: www.wgl.de Inhaltsverzeichnis Allgemeiner Überblick Vorwort ................................................................................................... 1 Die Struktur des Heinrich-Pette-Instituts .............................................. 2 Modernisierung des HPI erfolgreich abgeschlossen ............................ 4 60 Jahre HPI .............................................................................................. 5 Offen für den Dialog .............................................................................. 6 Preisverleihungen und Ehrungen .......................................................... 8 Personelle Veränderungen in
    [Show full text]
  • Inhibition of HIV-1 by an Anti-Integrase Single-Chain Variable
    Gene Therapy (1999) 6, 660–666 1999 Stockton Press All rights reserved 0969-7128/99 $12.00 http://www.stockton-press.co.uk/gt Inhibition of HIV-1 by an anti-integrase single-chain variable fragment (SFv): delivery by SV40 provides durable protection against HIV-1 and does not require selection M BouHamdan1, L-X Duan1, RJ Pomerantz1 and DS Strayer1,2 1The Dorrance H Hamilton Laboratories, Center for Human Virology, Division of Infectious Diseases, Department of Medicine; and 2Department of Pathology, Anatomy and Cell Biology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA, USA Human immunodeficiency virus type I (HIV-1) encodes the SFv-IN was confirmed by Western blotting and several proteins that are packaged into virus particles. Inte- immunofluorescence staining, which showed that Ͼ90% of grase (IN) is an essential retroviral enzyme, which has SupT1 T-lymphocytic cells treated with SV(Aw) expressed been a target for developing agents to inhibit virus repli- the SFv-IN protein without selection. When challenged, cation. In previous studies, we showed that intracellular HIV-1 replication, as measured by HIV-1 p24 antigen expression of single-chain variable antibody fragments expression and syncytium formation, was potently inhibited (SFvs) that bind IN, delivered via retroviral expression vec- in cells expressing SV40-delivered SFv-IN. Levels of inhi- tors, provided resistance to productive HIV-1 infection in bition of HIV-1 infection achieved using this approach were T-lymphocytic cells. In the current studies, we evaluated comparable to those achieved using murine leukemia virus simian-virus 40 (SV40) as a delivery vehicle for anti-IN (MLV) as a transduction vector, the major difference being therapy of HIV-1 infection.
    [Show full text]
  • Hepatitis B Virus X Protein Inhibits P53 Sequence-Specific DNA Binding
    Proc. Nati. Acad. Sci. USA Vol. 91, pp. 2230-2234, March 1994 Medical Sciences Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3 XIN WEI WANG*, KATHLEEN FORRESTER*, HEIDI YEH*, MARK A. FEITELSONt, JEN-REN GUI, AND CURTIS C. HARRIS*§ *Laboratory of Human Carcinogenesis, Division of Cancer Etiology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; tDepartment of Pathology and Cell Biology, Jefferson Medical College, Philadelphia, PA 19107; and tDepartment of Molecular Biology and Biochemistry, Shanghai Cancer Institute, Shanghai, People's Republic of China. Communicated by Bert Vogelstein, December 27, 1993 (receivedfor review December 9, 1993) ABSTRACT Chronic active hepatitis caused by infection about the role of HBX in HCC development. In this report, with hepatitis B virus, a DNA virus, is a major risk factor for we present results consistent with the hypothesis that HBX human hepatocellular carcinoma. Since the oncogenicity of binds to p53 and abrogates its normal cellular functions. several DNA viruses is dependent on the interaction of their viral oncoproteins with cellular tumor-suppressor gene prod- MATERIAL AND METHODS ucts, we investigated the interaction between hepatitis B virus X protein (HBX) and human wild-type p53 protein. HBX Plasmids. Plasmid constructs encoding GST-p53-WT, con- complexes with the wild-type p53 protein and inhibits its taining glutathione S-transferase (GST) fused to human wild- sequence-specific DNA binding in vitro. HBX expresslin also type p53, and GST-p53-135Y, containing GST fused to the inhibits p53-mediated transcrptional activation in vivo and the mutant p53 containing a His -* Tyr mutation at codon 135, in vitro asoition of p53 and ERCC3, a general transcription were provided by Jon Huibregtse (National Cancer Institute) factor involved in nucleotide excision repair.
    [Show full text]
  • PP2A-Dependent Disruption of Centrosome Replication and Cytoskeleton Organization in Drosophila by SV40 Small Tumor Antigen
    Oncogene (2008) 27, 6334–6346 & 2008 Macmillan Publishers Limited All rights reserved 0950-9232/08 $32.00 www.nature.com/onc ORIGINAL ARTICLE PP2A-dependent disruption of centrosome replication and cytoskeleton organization in Drosophila by SV40 small tumor antigen S Kotadia1,LRKao1, SA Comerford2, RT Jones1, RE Hammer3 and TL Megraw1 1Department of Pharmacology, The Cecil and Ida Green Center for Reproductive Biology Sciences, The University of Texas Southwestern Medical Center at Dallas, Dallas, TX, USA; 2Department of Molecular Genetics, The Cecil and Ida Green Center for Reproductive Biology Sciences, The University of Texas Southwestern Medical Center at Dallas, Dallas, TX, USA and 3Department of Biochemistry, The Cecil and Ida Green Center for Reproductive Biology Sciences, The University of Texas Southwestern Medical Center at Dallas, Dallas, TX, USA Viruses of the DNA tumor virus family share the ability to cell-cycle and apoptosis regulation, viral oncoproteins transform vertebrate cells through the action of virus- transform cells. Investigation of DNA tumor virus encoded tumor antigens that interfere with normal cell oncoproteins has led to the identification of many physiology. They accomplish this very efficiently by fundamental mechanisms of tumor suppression (Lavia inhibiting endogenous tumor suppressor proteins that et al., 2003; Ahuja et al., 2005). By altering the activity control cell proliferation and apoptosis. Simian virus 40 of p53, retinoblastoma protein and serine/threonine (SV40) encodes two oncoproteins, large tumor antigen, protein phosphatase 2A (PP2A), three key tumor which directly inhibits the tumor suppressors p53 and Rb, suppressors, SV40 can cause tumor formation in and small tumor antigen (ST), which interferes with transgenic mouse models (Ahuja et al., 2005; Arroyo serine/threonine protein phosphatase 2A (PP2A).
    [Show full text]
  • The Simian Virus 40 Large Tumor Antigen Activates Csrc and Requires Csrc for Full Neoplastic Transformation
    ANTICANCER RESEARCH 30: 47-54 (2010) The Simian Virus 40 Large Tumor Antigen Activates cSrc and Requires cSrc for Full Neoplastic Transformation ROZANNE ARULANANDAM, MULU GELETU and LEDA RAPTIS Departments of Microbiology and Immunology and Pathology, Queen's University, Kingston, Ontario, K7L 3N6, Canada Abstract. Aim: To investigate the role of the cellular The effects of TAg on the Rb family proteins are thought to be protooncogene product, cSrc, in neoplastic transformation by exerted by regulating the activity of the E2F transcription factors. the large tumor antigen of simian virus 40 (TAg), the ability of There are eight known E2F proteins (E2F1-8), all of which TAg to increase cSrc activity was examined. Materials and possess a DNA-binding domain that governs their interactions Methods: cSrc activity was measured in cells expressing wild- with a common consensus sequence present in the promoters of type or mutant TAg and compared to the parental line. Results: a number of genes (reviewed in (4, 5)). In quiescent cells, E2F- The results indicated that TAg expression in mouse 3T3 regulated genes are not expressed because their promoters are fibroblasts causes a dramatic increase in cSrc activity, a finding occupied primarily by p130/E2F4 complexes which repress which establishes TAg as a cSrc activator. This ability transcription. Following receptor stimulation, Rb proteins are depended upon a TAg, intact retinoblastoma-susceptibility gene inactivated through phosphorylation by the cyclin-dependent product (Rb) family-binding site. In addition, genetic ablation kinases and this results in the replacement of the p130/E2F4 of pRb in mouse fibroblasts increased cSrc activity, suggesting complexes by the ‘activating’ E2F1-3.
    [Show full text]
  • Identification of Rab18 As an Essential Host Factor for Bkpyv Infection Using a Whole Genome RNA 2 Interference Screen
    bioRxiv preprint doi: https://doi.org/10.1101/157602; this version posted June 29, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Identification of Rab18 as an Essential Host Factor for BKPyV Infection Using a Whole Genome RNA 2 Interference Screen 3 4 Linbo Zhaoa, Michael J. Imperialea,b,* 5 6 aDepartment of Microbiology and Immunology, bComprehensive Cancer Center, University of Michigan, 7 Ann Arbor, MI, 48109, USA 8 9 10 11 12 13 14 15 16 17 18 * Corresponding author. Department of Microbiology and Immunology, 1150 West Medical Center 19 Drive, 5724 Medical Science II, Ann Arbor, MI 48109-5620, USA. Tel. +1 (734) 763 9162. Fax: +1 (734) 20 764 3562. 21 E-mail addresses: [email protected] (L. Zhao); [email protected] (M.J. Imperiale). 22 23 24 1 bioRxiv preprint doi: https://doi.org/10.1101/157602; this version posted June 29, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 25 Abstract 26 27 BK polyomavirus (BKPyV) is a human pathogen first isolated in 1971. BKPyV infection is ubiquitous in the 28 human population, with over 80% of adults worldwide being seropositive for BKPyV. BKPyV infection is 29 usually asymptomatic; however, BKPyV reactivation in immunosuppressed transplant patients causes 30 two diseases, polyomavirus-associated nephropathy and hemorrhagic cystitis.
    [Show full text]
  • Interactions Between Polyomavirus Large T Antigen and the Viral Replication Origin Dna: How and Why
    INTERACTIONS BETWEEN POLYOMAVIRUS LARGE T ANTIGEN AND THE VIRAL REPLICATION ORIGIN DNA: HOW AND WHY by Yu-Cai Peng Department of Microbiology and Immunology McGill University, Montreal April, 1999 A thesis submitted to the Faculty of Craduate Studies and Re3earch in partial fulfullmeat of the requirements of the degree of doctor of philosophy @Yu-Cai Peng, 1999 National Library Biblioth ue nationale 1+1 of Canada du Cana7 a Acquisitions and Acquisitions et Bibliographie Srvices services bibliographiques 395 Wellmgton Street 395, nie Weliingîm Ottawa ON KIA ON4 OrtawaON K1AON4 Canada Canada The author has granted a non- L'auteur a accordé une licence non exclusive Licence ailowing the exclusive permettant à la National Library of Canada to Bibliothèque nationale du Canada de reproduce, loan, distribute or sell reproduire, prêter, distribuer ou copies of this thesis in microform, vendre des copies de cette thèse sous paper or electronic formats. la forme de microfichelfilm, de reproduction sur papier ou sur format électronique. The author retains ownership of the L'auteur conserve la propriété du copyright in this thesis. Neither the droit d'auteur qui protège cette thèse. thesis nor substantial extracts fkom it Ni la thèse ni des extraits substantiels may be printed or othenvise de celle-ci ne doivent être imprimés reproduced without the author's ou autrement reproduits sans son permission. autorisation. TABLE OF CONTENTS Page Tableofcontents................................................... I Abstract .......................................................... VI Resumé........................................................... VI11 Acknowledgements ................................................. X Claim of contribution to kaowledge ................................... XI Listoffigures ...................................................... XllI Guidelines regarding doctoral thesis ................................... XV CHAPTER 1. INTRODUCTION .................................... 1 1. Overview: Life cycle of polyomavirus and simian virus 40 ..........
    [Show full text]
  • Human Merkel Cell Polyomavirus Small T Antigen Is an Oncoprotein
    Research article Human Merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4E-BP1 translation regulator Masahiro Shuda, Hyun Jin Kwun, Huichen Feng, Yuan Chang, and Patrick S. Moore Cancer Virology Program, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. Merkel cell polyomavirus (MCV) is the recently discovered cause of most Merkel cell carcinomas (MCCs), an aggressive form of nonmelanoma skin cancer. Although MCV is known to integrate into the tumor cell genome and to undergo mutation, the molecular mechanisms used by this virus to cause cancer are unknown. Here, we show that MCV small T (sT) antigen is expressed in most MCC tumors, where it is required for tumor cell growth. Unlike the closely related SV40 sT, MCV sT transformed rodent fibroblasts to anchorage- and contact-independent growth and promoted serum-free proliferation of human cells. These effects did not involve protein phosphatase 2A (PP2A) inhibition. MCV sT was found to act downstream in the mam- malian target of rapamycin (mTOR) signaling pathway to preserve eukaryotic translation initiation factor 4E–binding protein 1 (4E-BP1) hyperphosphorylation, resulting in dysregulated cap-dependent translation. MCV sT–associated 4E-BP1 serine 65 hyperphosphorylation was resistant to mTOR complex (mTORC1) and mTORC2 inhibitors. Steady-state phosphorylation of other downstream Akt-mTOR targets, including S6K and 4E-BP2, was also increased by MCV sT. Expression of a constitutively active 4E-BP1 that could not be phosphorylated antagonized the cell transformation activity of MCV sT. Taken together, these experiments showed that 4E-BP1 inhibition is required for MCV transformation. Thus, MCV sT is an oncoprotein, and its effects on dysregulated cap-dependent translation have clinical implications for the prevention, diagnosis, and treatment of MCV-related cancers.
    [Show full text]
  • Autophagy, Evs, and Infections: a Perfect Question for a Perfect Time
    REVIEW published: 18 October 2018 doi: 10.3389/fcimb.2018.00362 Autophagy, EVs, and Infections: A Perfect Question for a Perfect Time Michelle L. Pleet 1†, Heather Branscome 1†, Catherine DeMarino 1, Daniel O. Pinto 1, Mohammad Asad Zadeh 1, Myosotys Rodriguez 2, Ilker Kudret Sariyer 3, Nazira El-Hage 2 and Fatah Kashanchi 1* 1 Laboratory of Molecular Virology, School of Systems Biology, George Mason University, Manassas, VA, United States, 2 Department of Immunology, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, United States, 3 Department of Neuroscience, Center for Neurovirology, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, United States Autophagy, a highly conserved process, serves to maintain cellular homeostasis in response to an extensive variety of internal and external stimuli. The classic, or canonical, pathway of autophagy involves the coordinated degradation and recycling of intracellular components and pathogenic material. Proper regulation of autophagy is critical to Edited by: maintain cellular health, as alterations in the autophagy pathway have been linked to the Wenjun Liu, Institute of Microbiology (CAS), China progression of a variety of physiological and pathological conditions in humans, namely Reviewed by: in aging and in viral infection. In addition to its canonical role as a degradative pathway, a Maria Teresa Sanchez-Aparicio, more unconventional and non-degradative role for autophagy has emerged as an area of Icahn School of Medicine at Mount Sinai, United States increasing interest. This process, known as secretory autophagy, is gaining widespread Alan G. Goodman, attention as many viruses are believed to use this pathway as a means to release and Washington State University, spread viral particles.
    [Show full text]
  • Drosophila As a Model for Infectious Diseases
    International Journal of Molecular Sciences Review Drosophila as a Model for Infectious Diseases J. Michael Harnish 1,2 , Nichole Link 1,2,3,† and Shinya Yamamoto 1,2,4,5,* 1 Department of Molecular and Human Genetics, Baylor College of Medicine (BCM), Houston, TX 77030, USA; [email protected] (J.M.H.); [email protected] (N.L.) 2 Jan and Dan Duncan Neurological Research Institute, Texas Children’s Hospital, Houston, TX 77030, USA 3 Howard Hughes Medical Institute, Houston, TX 77030, USA 4 Department of Neuroscience, BCM, Houston, TX 77030, USA 5 Development, Disease Models and Therapeutics Graduate Program, BCM, Houston, TX 77030, USA * Correspondence: [email protected]; Tel.: +1-832-824-8119 † Current Affiliation: Department of Neurobiology, University of Utah, Salt Lake City, UT 84112, USA. Abstract: The fruit fly, Drosophila melanogaster, has been used to understand fundamental principles of genetics and biology for over a century. Drosophila is now also considered an essential tool to study mechanisms underlying numerous human genetic diseases. In this review, we will discuss how flies can be used to deepen our knowledge of infectious disease mechanisms in vivo. Flies make effective and applicable models for studying host-pathogen interactions thanks to their highly con- served innate immune systems and cellular processes commonly hijacked by pathogens. Drosophila researchers also possess the most powerful, rapid, and versatile tools for genetic manipulation in multicellular organisms. This allows for robust experiments in which specific pathogenic proteins can be expressed either one at a time or in conjunction with each other to dissect the molecular functions of each virulent factor in a cell-type-specific manner.
    [Show full text]
  • Trans-Activation of the JC Virus Late Promoter by the Tat Protein
    Proc. Natl. Acad. Sci. USA Vol. 87, pp. 3479-3483, May 1990 Biochemistry Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells HIROOMI TADA*, JAY RAPPAPORTt, MONIR LASHGARI*, SHOHREH AMINI*, FLOSSIE WONG-STAALt, AND KAMEL KHALILI*t *Department of Biochemistry and Molecular Biology, Jefferson Institute of Molecular Medicine, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA 19107; and TLaboratory of Tumor Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 Communicated by Robert C. Gallo, February 9, 1990 ABSTRACT Progressive multifocal leukoencephalopathy culture (18). It has been shown that the highly restricted host (PML) is a demyelinating disease of the central nervous system range/tissue specificity of JCV to glial cells rests in the caused by the JC virus (JCV), a human papovavirus. PML is expression of its viral genome (20-22). It would appear that a relatively rare disease seen predominantly in immunocom- the JCV control region contains a regulatory element(s) that promised individuals and is a frequent complication observed is recognized by trans-acting factors present predominantly in AIDS patients. The significantly higher incidence ofPML in in glial cells. AIDS patients than in other immunosuppressive disorders has Although PML is a relatively infrequent disorder, latent suggested that the presence of human immunodeficiency virus infection with JCV appears to be fairly common (15). Virus type 1 (HIV-1) in the brain may directly or indirectly contribute reactivation and resulting neuropathology appears to be a to the pathogenesis ofthis disease. In the present study we have consequence of the suppression of cell-mediated immunity.
    [Show full text]
  • Molecular Characterization of Resistance to Radiation in a Small Subset of Tumor Cells Induced by Jc Virus T-Ag in Mice
    UNIVERSITÀ DEGLI STUDI DI MILANO SCUOLA DOTTORATO IN MEDICINA MOLECOLARE E TRASLAZIONALE CICLO XXX TESI DI DOTTORATO DI RICERCA Settore Scientifico Disciplinare MED/04 MOLECULAR CHARACTERIZATION OF RESISTANCE TO RADIATION IN A SMALL SUBSET OF TUMOR CELLS INDUCED BY JC VIRUS T-AG IN MICE Dottorando: Martina DONADONI Matricola N° R10816 Tutor: Dott.ssa Nicoletta BASILICO Co-Tutor: Dr. Ilker K. SARIYER Coordinatore del dottorato: Prof. Riccardo GHIDONI Anno Accademico 2016/2017 ABSTRACT JCV is a small, naked tumor polyomavirus with an icosahedral capsids containing a circular, double-stranded DNA genome. Its genome is divided into early and late genes, separated by a non-coding control region (NCCR) containing the promoter, the origin of replication (ORI) and the enhancer elements. Early genes encode for large T antigen, small t antigen and three different T’ proteins called T’135, T’136 and T’165. Late genes encode for the structural proteins VP1, VP2 and VP3, and the non-structural agnoprotein. JCV only replicates in human. In non-permissive cells, they are not able to support viral replication or expression of late genes. In those cells, only the transcription of early genes is observed, such as large T antigen. This leads to genome instability and inactivation of oncosoppressor proteins and eventually tumorigenesis. Cells derived from a murine brain tumor induced by JCV injection have shown different resistance to ionizing radiation. We cultured these BSB8-RR cells and characterized them comparing to the radiation sensitive BSB8 cells. Using MTT assay we showed a resistance to radiation to these cells, compare to the BSB8.
    [Show full text]